These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35224081)

  • 1. Emergence and Mechanism of Resistance of Tulathromycin Against
    Xia X; Yang L; Ling Y; Yu J; Ding H
    Front Vet Sci; 2022; 9():801800. PubMed ID: 35224081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PK/PD Integration and Resistance of Tilmicosin against
    Huang Z; Hu Z; Zheng H; Xia X; Gu X; Shen X; Yang H; Ding H
    Pathogens; 2020 Jun; 9(6):. PubMed ID: 32575357
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic integration and resistance of tiamulin against Mycoplasma hyopneumoniae in an in vitro dynamic model.
    Huang Z; Xia X; Mao C; Gu X; Shen X; Yang H; Ding H
    Microb Pathog; 2020 Oct; 147():104255. PubMed ID: 32407861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility testing of Mycoplasma hyopneumoniae field isolates from Central Europe for fifteen antibiotics by microbroth dilution method.
    Felde O; Kreizinger Z; Sulyok KM; Hrivnák V; Kiss K; Jerzsele Á; Biksi I; Gyuranecz M
    PLoS One; 2018; 13(12):e0209030. PubMed ID: 30533041
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Huang Z; Wu Y; Zhou Z; Xia X; Gu X; Cai Q; Shen X; Yang H; Ding H
    Front Pharmacol; 2019; 10():670. PubMed ID: 31293418
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Guo LL; Gao RY; Wang LH; Lin SJ; Fang BH; Zhao YD
    Front Vet Sci; 2021; 8():715887. PubMed ID: 34869712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of macrolide resistance in Mycoplasma gallisepticum in vitro and its resistance-related mutations within domain V of 23S rRNA.
    Wu CM; Wu H; Ning Y; Wang J; Du X; Shen J
    FEMS Microbiol Lett; 2005 Jun; 247(2):199-205. PubMed ID: 15936901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of In Vivo acquired resistance of Mycoplasma hyopneumoniae to macrolides and lincosamides.
    Stakenborg T; Vicca J; Butaye P; Maes D; Minion FC; Peeters J; De Kruif A; Haesebrouck F
    Microb Drug Resist; 2005; 11(3):290-4. PubMed ID: 16201934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of Macrolide Resistance Genotypes in
    Kinnear A; McAllister TA; Zaheer R; Waldner M; Ruzzini AC; Andrés-Lasheras S; Parker S; Hill JE; Jelinski MD
    Pathogens; 2020 Jul; 9(8):. PubMed ID: 32751555
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of tulathromycin against Haemophilus parasuis in an experimental neutropenic guinea pig model.
    Zhao Y; Guo LL; Fang B; Liu B
    PLoS One; 2018; 13(12):e0209177. PubMed ID: 30596709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic/Pharmacodynamic Modeling of Tulathromycin against
    Zhou Q; Zhang G; Wang Q; Liu W; Huang Y; Yu P; Li Y; Ding H; Fang B
    Front Pharmacol; 2017; 8():392. PubMed ID: 28701951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/Pharmacodynamic Integration of Doxycycline Against
    Zhang H; Mao C; Li J; Huang Z; Gu X; Shen X; Ding H
    Front Pharmacol; 2019; 10():1088. PubMed ID: 31620004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/Pharmacodynamic Relationships of Tulathromycin Against
    Yao L; Yang L; Ling Y; Wei Y; Shen X; Ding H
    Front Vet Sci; 2022; 9():822432. PubMed ID: 35419449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility monitoring of Mycoplasma hyopneumoniae isolated from seven European countries during 2015-2016.
    de Jong A; Youala M; Klein U; El Garch F; Moyaert H; Simjee S; Maes D; Gyuranecz M; Pridmore A; Thomson JR; Ayling RD;
    Vet Microbiol; 2021 Feb; 253():108973. PubMed ID: 33418394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolide-Resistance Selection in Tibetan Pigs with a High Load of Mycoplasma hyopneumoniae.
    Qiu G; Rui Y; Zhang J; Zhang L; Huang S; Wu Q; Li K; Han Z; Liu S; Li J
    Microb Drug Resist; 2018 Sep; 24(7):1043-1049. PubMed ID: 29271698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for
    Zhou YF; Peng HM; Bu MX; Liu YH; Sun J; Liao XP
    Front Pharmacol; 2017; 8():684. PubMed ID: 29033841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae.
    Hannan PC; Windsor HM; Ripley PH
    Res Vet Sci; 1997; 63(2):157-60. PubMed ID: 9429250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired resistance to the 16-membered macrolides tylosin and tilmicosin by Mycoplasma bovis.
    Lerner U; Amram E; Ayling RD; Mikula I; Gerchman I; Harrus S; Teff D; Yogev D; Lysnyansky I
    Vet Microbiol; 2014 Jan; 168(2-4):365-71. PubMed ID: 24393633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of in vivo-acquired resistance to macrolides of Mycoplasma gallisepticum strains isolated from poultry.
    Gerchman I; Levisohn S; Mikula I; Manso-Silván L; Lysnyansky I
    Vet Res; 2011 Aug; 42(1):90. PubMed ID: 21810258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility monitoring of Mycoplasma hyopneumoniae and Mycoplasma bovis isolated in Europe.
    Klein U; de Jong A; Moyaert H; El Garch F; Leon R; Richard-Mazet A; Rose M; Maes D; Pridmore A; Thomson JR; Ayling RD
    Vet Microbiol; 2017 May; 204():188-193. PubMed ID: 28532800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.